Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$732
|
$693B |
12.4x |
29.4x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$175
|
$454B |
5.0x |
13.5x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$208
|
$431B |
7.3x |
15.9x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 263
|
$285B |
3.7x |
9.4x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£119
|
$273B |
4.7x |
13.6x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 102
|
$269B |
4.9x |
11.9x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 359
|
$260B |
5.4x |
11.0x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$83
|
$235B |
3.6x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$286
|
$202B |
5.8x |
10.9x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$113
|
$159B |
5.5x |
11.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$133B |
2.8x |
9.3x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€87
|
$131B |
2.5x |
8.4x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£15
|
$98.3B |
2.3x |
6.8x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$392
|
$95.7B |
8.2x |
24.7x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 213
|
$75.4B |
4.8x |
14.5x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4431
|
$74.7B |
2.4x |
9.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$74.0B |
7.8x |
18.1x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$70.3B |
1.3x |
6.2x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6480
|
$64.9B |
8.0x |
15.8x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€108
|
$63.7B |
2.6x |
9.1x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 570
|
$54.0B |
6.0x |
20.8x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 63
|
$53.4B |
12.1x |
42.1x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3592
|
$42.2B |
3.2x |
15.2x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1586
|
$40.8B |
6.6x |
23.0x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 60
|
$35.3B |
2.1x |
7.3x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 50
|
$31.1B |
2.8x |
13.4x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 172400
|
$28.9B |
10.1x |
30.7x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7838
|
$26.4B |
1.6x |
7.0x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$26.1B |
1.8x |
6.1x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1620
|
$23.8B |
1.8x |
8.9x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$23.4B |
12.2x |
32.7x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$133
|
$23.3B |
2.4x |
7.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.5B |
2.3x |
6.6x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$21.9B |
7.5x |
8.0x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 91
|
$19.1B |
12.4x |
198.7x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$18.1B |
2.1x |
8.5x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 324
|
$18.1B |
39.0x |
130.9x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 152
|
$17.1B |
41.2x |
-6126.0x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$16.6B |
3.8x |
15.0x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 418000
|
$15.6B |
109.8x |
208.2x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€53
|
$15.1B |
5.1x |
13.6x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3577
|
$14.2B |
10.2x |
31.1x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1579
|
$13.4B |
4.2x |
16.5x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$139
|
$13.2B |
5.0x |
20.8x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 454
|
$12.9B |
47.7x |
-334.1x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 27
|
$12.9B |
2.2x |
14.2x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1613
|
$12.7B |
3.6x |
9.7x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$12.5B |
3.1x |
11.6x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2475
|
$12.4B |
8.2x |
32.2x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.4B |
2.2x |
15.5x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1261
|
$11.8B |
3.1x |
12.0x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.3x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 293
|
$11.7B |
4.1x |
11.2x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€68
|
$11.4B |
5.9x |
18.5x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2561
|
$11.0B |
3.5x |
8.9x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 977
|
$10.7B |
3.9x |
13.5x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€117
|
$10.5B |
2.5x |
7.0x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 24
|
$10.5B |
3.3x |
8.2x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 44
|
$10.3B |
1.7x |
13.2x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1902
|
$10.2B |
3.8x |
15.6x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$73
|
$9.5B |
7.8x |
11.9x |
Verona Pharma
|
United States of America |
Biopharmaceuticals
|
$106
|
$9.0B |
30.2x |
-362.5x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4597
|
$8.4B |
1.6x |
12.8x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€162
|
$8.4B |
N/A |
N/A |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 28
|
$8.0B |
4.0x |
7.0x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 54
|
$7.8B |
10.5x |
34.6x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 39
|
$7.7B |
N/A |
N/A |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 190
|
$7.6B |
18.7x |
26.4x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2544
|
$7.4B |
2.3x |
9.9x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 31490
|
$7.3B |
9.6x |
35.6x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5376
|
$7.1B |
4.6x |
23.3x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 353
|
$6.9B |
3.8x |
18.0x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1026
|
$6.8B |
1.8x |
8.9x |
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 51
|
$6.8B |
N/A |
N/A |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£18
|
$6.8B |
2.1x |
7.8x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 90
|
$6.7B |
19.6x |
-117.8x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 30
|
$6.5B |
1.6x |
8.3x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1935
|
$6.3B |
4.0x |
21.1x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€200
|
$6.2B |
2.7x |
9.9x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 115133
|
$6.1B |
4.0x |
54.3x |
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€69
|
$6.0B |
522.9x |
-30.3x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$5.9B |
5.0x |
16.3x |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 64
|
$5.9B |
7.2x |
25.1x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 43
|
$5.7B |
17.3x |
-53.0x |
Gan & Lee Pharmaceuticals
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 71
|
$5.7B |
10.6x |
34.8x |
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 74
|
$5.5B |
6.8x |
30.5x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.5B |
1.9x |
8.3x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 20
|
$5.3B |
5.8x |
14.1x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10490
|
$5.2B |
2.0x |
5.3x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1658
|
$5.2B |
1.6x |
7.0x |
Peptron
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics,
Drug Delivery Systems
|
KRW 317500
|
$5.2B |
N/A |
N/A |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 102
|
$5.2B |
2.8x |
11.2x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2748
|
$5.0B |
11.4x |
36.0x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 288
|
$4.8B |
N/A |
N/A |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 502
|
$4.8B |
11.0x |
38.6x |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 83
|
$4.6B |
9.6x |
31.2x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 64
|
$4.3B |
12.4x |
87.0x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 107
|
$4.3B |
1.7x |
7.0x |